Background: Digital retinal imaging is the gold standard technique for diabetic retinopathy (DR) and diabetic macular oedema (DME) assessment during DR screening. Objectives: To evaluate the diagnostic accuracy of digital retinal fundus image (DRFI) analysis in detecting DME using three manual grading systems (MGS) and comparing it with optical coherence tomography (OCT) findings. Method: A total of 287 DRFI of 287 eyes were analysed. Non-stereoscopic 45° images were acquired using a Kowa VX-20 camera and were graded according to three MGS: Early Treatment Diabetic Retinopathy Study (ETDRS), International Clinical Diabetic Retinopathy (ICDR), and United Kingdom National Screening Committee (UKNSC). The two graders were masked to the patient’s clinical DR status. DME characteristics were analysed using OCTs. Results: A very good agreement in detecting DME was found with Cohen’s κ = 0.83 (ICDR vs. ETDRS), κ = 0.83 (ICDR vs. UKNSC), and κ = 0.82 (ETDRS vs. UKNSC). Sensitivity and specificity of DRFI analysis in DME assessment were 70.0 and 69.6% for UKNSC, 71.9 and 67.4% for ETDRS, and 70.9 and 65.2% for ICDR, respectively. Positive and negative predictive values were 91.7 and 32.7% for UKNSC, 91.4 and 33.3% for ETDRS, and 90.7 and 31.9% for ICDR, respectively. On OCT scans, micro-architectural damages of both inner and outer retinal layers and mean ganglion cell layer thickness showed a significant association with the presence of DME detected with DRFI analysis. Conclusions: Despite the low negative predictive value, the good specificity and sensitivity of DRFI in detecting DME make it a useful tool in a routine clinical setting, and its potential in diabetic eye screening is yet to be realized.

1.
Flaxman
SR
,
Bourne
RR
,
Resnikoff
S
,
Ackland
P
,
Braithwaite
T
,
Cicinelli
MV
, et al;
Vision Loss Expert Group of the Global Burden of Disease Study
.
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
.
Lancet Glob Health
.
2017
Dec
;
5
(
12
):
e1221
34
.
[PubMed]
2214-109X
2.
Ferris
FL
 3rd
.
How effective are treatments for diabetic retinopathy?
JAMA
.
1993
Mar
;
269
(
10
):
1290
1
.
[PubMed]
0098-7484
3.
Vujosevic
S
,
Pucci
P
,
Casciano
M
,
Daniele
A
,
Bini
S
,
Berton
M
, et al
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy
.
J Diabetes Complications
.
2017
Aug
;
31
(
8
):
1348
53
.
[PubMed]
1056-8727
4.
van Eijk
KN
,
Blom
JW
,
Gussekloo
J
,
Polak
BC
,
Groeneveld
Y
.
Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance
.
Diabetes Res Clin Pract
.
2012
Apr
;
96
(
1
):
10
6
.
[PubMed]
0168-8227
5.
Peto
T
,
Tadros
C
.
Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom
.
Curr Diab Rep
.
2012
Aug
;
12
(
4
):
338
45
.
[PubMed]
1534-4827
6.
Scanlon
PH
,
Aldington
SJ
,
Stratton
IM
.
Epidemiological issues in diabetic retinopathy
.
Middle East Afr J Ophthalmol
.
2013
Oct-Dec
;
20
(
4
):
293
300
.
[PubMed]
0974-9233
7.
Zimmer-Galler
IE
,
Kimura
AE
,
Gupta
S
.
Diabetic retinopathy screening and the use of telemedicine
.
Curr Opin Ophthalmol
.
2015
May
;
26
(
3
):
167
72
.
[PubMed]
1040-8738
8.
Mudie
LI
,
Wang
X
,
Friedman
DS
,
Brady
CJ
.
Crowdsourcing and Automated Retinal Image Analysis for Diabetic Retinopathy
.
Curr Diab Rep
.
2017
Sep
;
17
(
11
):
106
.
[PubMed]
1534-4827
9.
Adhi
M
,
Brewer
E
,
Waheed
NK
,
Duker
JS
.
Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography
.
JAMA Ophthalmol
.
2013
Oct
;
131
(
10
):
1267
74
.
[PubMed]
2168-6165
10.
Olson
J
,
Sharp
P
,
Goatman
K
,
Prescott
G
,
Scotland
G
,
Fleming
A
, et al
Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
.
Health Technol Assess
.
2013
Nov
;
17
(
51
):
1
142
.
[PubMed]
1366-5278
11.
Williams
GA
,
Scott
IU
,
Haller
JA
,
Maguire
AM
,
Marcus
D
,
McDonald
HR
.
Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology
.
Ophthalmology
.
2004
May
;
111
(
5
):
1055
62
.
[PubMed]
0161-6420
12.
Nieves-Moreno
M
,
Martínez-de-la-Casa
JM
,
Cifuentes-Canorea
P
,
Sastre-Ibáñez
M
,
Santos-Bueso
E
,
Sáenz-Francés
F
, et al
Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population
.
PLoS One
.
2017
Jul
;
12
(
7
):
e0180450
.
[PubMed]
1932-6203
13.
Portney
LG
,
Watkins
MP
.
Foundations of clinical resarch: applications to Tractice
. 2nd ed.
Pearson
;
2000
.
14.
Wild
S
,
Roglic
G
,
Green
A
,
Sicree
R
,
King
H
.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
.
Diabetes Care
.
2004
May
;
27
(
5
):
1047
53
.
[PubMed]
0149-5992
15.
Duh
EJ
,
Sun
JK
,
Stitt
AW
.
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
.
JCI Insight
.
2017
Jul
;
2
(
14
):
93751
.
[PubMed]
2379-3708
16.
Tufail
A
,
Kapetanakis
VV
,
Salas-Vega
S
,
Egan
C
,
Rudisill
C
,
Owen
CG
, et al
An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness
.
Health Technol Assess
.
2016
Dec
;
20
(
92
):
1
72
.
[PubMed]
1366-5278
17.
NHS Diabetic Eye Screening Programme
. Summary statistics: England, 1 April 2015 to 31 March
2016
. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/605040/Diabetic_eye_screening_summary_infographic_2015_to_2016.pdf
18.
Shelton
RL
,
Jung
W
,
Sayegh
SI
,
McCormick
DT
,
Kim
J
,
Boppart
SA
.
Optical coherence tomography for advanced screening in the primary care office
.
J Biophotonics
.
2014
Jul
;
7
(
7
):
525
33
.
[PubMed]
1864-063X
19.
Hussain
N
,
Edraki
M
,
Tahhan
R
,
Sanalkumar
N
,
Kenz
S
,
Akasha
NK
, et al
Telemedicine for diabetic retinopathy screening using an ultra-widefield fundus camera
.
Clin Ophthalmol
.
2017
Aug
;
11
:
1477
82
.
[PubMed]
1177-5467
20.
Virgili
G
,
Menchini
F
,
Dimastrogiovanni
AF
,
Rapizzi
E
,
Menchini
U
,
Bandello
F
, et al
Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review
.
Invest Ophthalmol Vis Sci
.
2007
Nov
;
48
(
11
):
4963
73
.
[PubMed]
0146-0404
21.
Li
HK
,
Hubbard
LD
,
Danis
RP
,
Florez-Arango
JF
,
Esquivel
A
,
Krupinski
EA
.
Comparison of multiple stereoscopic and monoscopic digital image formats to film for diabetic macular edema evaluation
.
Invest Ophthalmol Vis Sci
.
2010
Dec
;
51
(
12
):
6753
61
.
[PubMed]
0146-0404
22.
Cennamo
G
,
Vecchio
EC
,
Finelli
M
,
Velotti
N
,
de Crecchio
G
.
Evaluation of ischemic diabetic maculopathy with Fourier-domain optical coherence tomography and microperimetry
.
Can J Ophthalmol
.
2015
Feb
;
50
(
1
):
44
8
.
[PubMed]
0008-4182
23.
Kim
JT
,
Lee
DH
,
Joe
SG
,
Kim
JG
,
Yoon
YH
.
Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients
.
Invest Ophthalmol Vis Sci
.
2013
May
;
54
(
5
):
3378
84
.
[PubMed]
0146-0404
24.
Sun
JK
,
Radwan
SH
,
Soliman
AZ
,
Lammer
J
,
Lin
MM
,
Prager
SG
, et al
Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema
.
Diabetes
.
2015
Jul
;
64
(
7
):
2560
70
.
[PubMed]
0012-1797
25.
Du
Y
,
Veenstra
A
,
Palczewski
K
,
Kern
TS
.
Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina
.
Proc Natl Acad Sci USA
.
2013
Oct
;
110
(
41
):
16586
91
.
[PubMed]
0027-8424
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.